Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Testing effectiveness (Phase 2)WithdrawnNCT04105062What this trial is testingLS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric SurgeryWho this might be right forPancreatic CancerLiver CancerGastric Cancer+2 more Washington University School of Medicine
Testing effectiveness (Phase 2)UnknownNCT01283789What this trial is testingLapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer University of Kansas Medical Center 23
Early research (Phase 1)WithdrawnNCT02105350What this trial is testingMEK162 With Gemcitabine and Oxaliplatin in Biliary CancerWho this might be right forBiliary Tract CarcinomaGallbladder Carcinoma University Health Network, Toronto
Not applicableLooking for participantsNCT04854213What this trial is testingPRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)Who this might be right forColorectal Cancer Metastatic National Cancer Institute, Naples 25
Not applicableUnknownNCT03175146What this trial is testingSee Whether Stereotactic Body RadioTherapy (SBRT) Can Shrink Tumours Within the Liver SafelyWho this might be right forColonic NeoplasmsNeoplasm Metastasis AHS Cancer Control Alberta 30
Testing effectiveness (Phase 2)Study completedNCT00002842What this trial is testingLiver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal CancerWho this might be right forColorectal CancerMetastatic Cancer City of Hope Medical Center 49
Testing effectiveness (Phase 2)Study completedNCT00031278What this trial is testingSafety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast CancerWho this might be right forCarcinoma, Metastatic Breast Pfizer 12
Not applicableUnknownNCT03362138What this trial is testingArtificial Intelligence-assisted Evaluation of Pigmented Skin LesionsWho this might be right forMelanomaPigmented Skin LesionDysplastic Nevi Assuta Hospital Systems 80
Early research (Phase 1)Ended earlyNCT04748848What this trial is testingA Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive TherapyWho this might be right forLeukemia, Myeloid Celgene 1
Testing effectiveness (Phase 2)Study completedNCT03665285What this trial is testingA Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more NextCure, Inc. 109
Testing effectiveness (Phase 2)Active Not RecruitingNCT04258943What this trial is testingBosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid LeukemiaWho this might be right forPhiladelphia Chromosome Positive CMLAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous Leukemia+1 more Children's Oncology Group 60
Large-scale testing (Phase 3)Ended earlyNCT05223673What this trial is testingPhase 3 Study of Futuximab/Modotuximab in Combination With Trifluridine/Tipiracil Versus Trifluridine/Tipiracil Single Agent in Participants With Previously Treated Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Institut de Recherches Internationales Servier 7
Early research (Phase 1)Study completedNCT00750425What this trial is testingPhase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid TumoursWho this might be right forAdvanced Solid Tumors AstraZeneca 46
Early research (Phase 1)Ended earlyNCT02782403What this trial is testingAxitinib and Bosutinib in Treating Patients With Chronic, Accelerated, or Blastic Phase Chronic Myeloid LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia (CML)Blast Phase Chronic Myelogenous Leukemia (CML)Chronic Phase Phase Chronic Myelogenous Leukemia (CML)+1 more M.D. Anderson Cancer Center 4
Early research (Phase 1)Study completedNCT01969643What this trial is testingA Safety Study of SGN-LIV1A in Breast Cancer PatientsWho this might be right forHER2 Positive Breast NeoplasmsHormone Receptor Positive Breast NeoplasmsTriple Negative Breast Neoplasms+1 more Seagen Inc. 290
Testing effectiveness (Phase 2)Study completedNCT00556049What this trial is testingCombination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaNeoplasm Metastases Massachusetts General Hospital 72
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Not applicableEnded earlyNCT02455024What this trial is testingAn Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®Who this might be right forMyeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL Ariad Pharmaceuticals 3